Building Scientific Trust Virtually
“How do you build, manage, and grow global oncology teams in opposite time zones amidst a pandemic? It’s a question I asked myself as I accepted a new position eight months into the COVID-19 lockdown, knowing that my first interactions with a large part of our global teams would not be in person and that […]
Taking the Next Step: What We’ve Learned About CAR-T So Far, and What It Means Going Forward
A year ago, flush with the excitement of the FDA approval of the first chimeric antigen receptor T-cell (CAR-T) therapy for acute lymphoblastic leukemia (ALL), the AACR Annual Meeting focused considerable attention to CAR-T. The approval marked a significant milestone in cancer treatment for researchers and oncologists, which supplied a new ray of hope for […]
Cancer Doesn’t See Borders – And Neither Should Biotech
Headline after headline, we hear about precision medicine and advances in the treatment of challenging diseases that were previously almost always fatal. And thanks to the accelerating scientific advancements in biotechnology, we’re successfully battling subsets of diseases that seemed unbeatable less than a decade ago. Cancer is one example of this trend. No sooner did […]
